Condition: Arrhythmogenic Cardiomyopathy · PKP2-ACM · PKP2-ARVC · Sponsor: Lexeo Therapeutics
An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.
This description comes directly from the study's public registry record.
Person*: Lexeo Clinical Trials · 212-547-9879 · clinicaltrials@lexeotx.com
Always discuss trial participation with your own doctor first.
| Leland Stanford Junior University | Redwood City, California, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Northshore University Healthsystem Research Institute | Columbia, Maryland, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| University of Rochester | Rochester, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06976606